OncoDecipher vs Trobix Bio
OncoDecipher vs Trobix Bio, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: OncoDecipher is on 43/100 and Trobix Bio on 49/100.
Where each one leads
OncoDecipher
Leads on none of the measures we hold for both companies.
Trobix Bio
- our overall score: 49/100 against 43/100
- funding raised: $3.0M against $1.0M
At a glance
| Measure | OncoDecipher | Trobix Bio |
|---|---|---|
| What it is | OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. | Pioneering precision microbiome therapeutics for oncology using CRISPR and synthetic biology. |
| Category | Life Sciences, Cancer, Oncology, Mutation | Life Sciences, Microbiome, Oncology, Therapeutics |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2015 | 2019 |
| Headquarters | Cambridge, United States | San Diego, United States |
| Status | Inactive | Active |
Size, funding and growth
| Measure | OncoDecipher | Trobix Bio |
|---|---|---|
| Employees | Not published | 13 |
| Headcount growthLast 12 months | Not published | +115.3% |
| Total funding | $1.0M | $3.0M |
| Latest round | Seed | Series A |
| LinkedIn followers | Not published | 564 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | OncoDecipher | Trobix Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 49/100 |
| Traction | 30/100 | 44/100 |
| Team | 60/100 | 30/100 |
| Search visibility | 3/100 | 42/100 |
| Quality | 52/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (21/100) |
| Domain ratingLink authority, 0-100 | Not published | 5/100 |
OncoDecipher vs Trobix Bio: common questions
Which is better, OncoDecipher or Trobix Bio?
On our 0-100 score Trobix Bio rates higher (49/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do OncoDecipher and Trobix Bio compare on the numbers?
Trobix Bio leads on our overall score (49/100 against 43/100), funding raised ($3.0M against $1.0M).
Read the full OncoDecipher review and pricing or the Trobix Bio review and pricing. You can also browse other OncoDecipher alternatives we track.